• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病在不同种族群体中的分布:亚裔美国人是否代表了一个新的高危人群?

Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?

机构信息

Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA.

出版信息

J Gastroenterol Hepatol. 2011 Mar;26(3):501-9. doi: 10.1111/j.1440-1746.2010.06443.x.

DOI:10.1111/j.1440-1746.2010.06443.x
PMID:21332546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4937792/
Abstract

BACKGROUND AND AIM

Nonalcoholic fatty liver disease (NAFLD) is increasingly common worldwide. We explored clinical, laboratory, and histological features of NAFLD as well as risk factors for histologically advanced disease among under-represented ethno-racial groups.

METHODS

Patient records from one NAFLD clinic in California from 1998-2008 were reviewed. Biopsies were graded using Brunt criteria by a hepatopathologist blinded to clinical data. We used multivariate logistic regression to assess associations between ethno-racial group and histological severity of NAFLD, while controlling for other factors.

RESULTS

We identified 90 biopsy-proven cases of NAFLD. Mean age was 49 years (standard deviation [SD]= 11.6), and half were female. 52% of patients were Caucasian, 20% Latino-American, 18% Asian-American, and 10% Middle Eastern-American. There were significant differences among groups with respect to age, weight, body mass index (BMI), and grade of hepatic steatosis (all P < 0.05). In multivariate analysis, older age was associated with severe (Brunt ≥ 2) inflammation (odds ratio [OR] 1.1, P = 0.002) and severe (Brunt ≥ 3) fibrosis (OR 1.2, P = 0.001), diabetes was associated with severe inflammation (OR 3.18, P = 0.07) and severe fibrosis (OR 8.81, P = 0.002), and increased BMI was associated with severe fibrosis (OR 2.43, P = 0.07). Additionally, compared to Caucasians, Asian-Americans showed a trend toward an association with severe (Brunt > 2) steatosis (OR 3.83, P = 0.08) and severe inflammation (OR 5.42, P = 0.06).

CONCLUSIONS

The findings from this ethno-racially diverse clinic-based cohort are consistent with prior studies and also suggest that Asian-Americans may be at risk for advanced NAFLD. This may have implications for the prevention, evaluation, and treatment of patients with NAFLD that merit further study.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)在全球范围内越来越普遍。我们探讨了代表性不足的族裔群体中 NAFLD 的临床、实验室和组织学特征,以及组织学上进展性疾病的危险因素。

方法

回顾了 1998 年至 2008 年加利福尼亚州一家 NAFLD 诊所的患者记录。通过一位对临床数据盲法的肝病病理学家,使用 Brunt 标准对活检进行分级。我们使用多变量逻辑回归来评估族裔群体与 NAFLD 组织学严重程度之间的关联,同时控制其他因素。

结果

我们确定了 90 例经活检证实的 NAFLD 病例。平均年龄为 49 岁(标准差[SD]=11.6),其中一半为女性。52%的患者为白种人,20%为拉丁裔美国人,18%为亚裔美国人,10%为中东海湾地区裔美国人。各组在年龄、体重、体重指数(BMI)和肝脂肪变性程度方面存在显著差异(均 P <0.05)。多变量分析显示,年龄较大与严重(Brunt≥2)炎症(比值比[OR]1.1,P=0.002)和严重(Brunt≥3)纤维化(OR 1.2,P=0.001)相关,糖尿病与严重炎症(OR 3.18,P=0.07)和严重纤维化(OR 8.81,P=0.002)相关,BMI 增加与严重纤维化(OR 2.43,P=0.07)相关。此外,与白种人相比,亚裔美国人有发生严重(Brunt>2)脂肪变性(OR 3.83,P=0.08)和严重炎症(OR 5.42,P=0.06)的趋势。

结论

本项基于族裔多样性的临床队列研究结果与既往研究一致,还提示亚裔美国人可能存在发生进展性 NAFLD 的风险。这可能对 NAFLD 患者的预防、评估和治疗产生影响,值得进一步研究。

相似文献

1
Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?非酒精性脂肪性肝病在不同种族群体中的分布:亚裔美国人是否代表了一个新的高危人群?
J Gastroenterol Hepatol. 2011 Mar;26(3):501-9. doi: 10.1111/j.1440-1746.2010.06443.x.
2
Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease.新诊断慢性肝病患者中非酒精性脂肪肝的种族和民族分布
Hepatology. 2005 Feb;41(2):372-9. doi: 10.1002/hep.20554.
3
Ethnicity and nonalcoholic fatty liver disease.种族与非酒精性脂肪性肝病。
Hepatology. 2012 Mar;55(3):769-80. doi: 10.1002/hep.24726.
4
Prevalence and outcomes of non-alcoholic fatty liver disease (NAFLD) among Asian American adults in the United States.美国亚裔成年人中非酒精性脂肪性肝病(NAFLD)的患病率和结局。
Liver Int. 2019 Apr;39(4):748-757. doi: 10.1111/liv.14038. Epub 2019 Feb 13.
5
Serum 25-hydroxyvitamin-D and nonalcoholic fatty liver disease: Does race/ethnicity matter? Findings from the MESA cohort.血清 25-羟维生素 D 与非酒精性脂肪性肝病:种族/民族差异重要吗?来自 MESA 队列的研究结果。
Nutr Metab Cardiovasc Dis. 2020 Jan 3;30(1):114-122. doi: 10.1016/j.numecd.2019.09.004. Epub 2019 Sep 10.
6
Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016.美国 2011-2016 年非酒精性脂肪性肝病流行率及疾病认知度的种族差异。
J Intern Med. 2020 Jun;287(6):711-722. doi: 10.1111/joim.13035. Epub 2020 Mar 4.
7
ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.ADH1B∗2 与非酒精性脂肪性肝病严重程度降低相关,与酒精摄入无关。
Gastroenterology. 2020 Sep;159(3):929-943. doi: 10.1053/j.gastro.2020.05.054. Epub 2020 May 23.
8
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.血清铁蛋白是非酒精性脂肪性肝病患者组织学严重程度和肝纤维化进展的独立预测因子。
Hepatology. 2012 Jan;55(1):77-85. doi: 10.1002/hep.24706. Epub 2011 Dec 6.
9
The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients.非西班牙裔白人、非裔美国人及西班牙裔肥胖症手术患者的肝脏疾病组织学谱。
Am J Gastroenterol. 2009 Jan;104(1):64-9. doi: 10.1038/ajg.2008.12.
10
Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.2 型糖尿病患者非酒精性脂肪性肝病的组织病理学分期:患病率及相关因素。
Liver Int. 2011 May;31(5):700-6. doi: 10.1111/j.1478-3231.2011.02482.x. Epub 2011 Feb 20.

引用本文的文献

1
Racial and Ethnic Disparities in NAFLD: Harnessing Epigenetic and Gut Microbiota Pathways for Targeted Therapeutic Approaches.非酒精性脂肪性肝病中的种族和民族差异:利用表观遗传学和肠道微生物群途径制定靶向治疗方法。
Biomolecules. 2025 May 5;15(5):669. doi: 10.3390/biom15050669.
2
Nutrition and diet in the general U.S. Asian American population: A scoping review protocol.一般美国亚裔美国人的营养与饮食:范围综述方案。
PLoS One. 2024 Aug 23;19(8):e0309219. doi: 10.1371/journal.pone.0309219. eCollection 2024.
3
Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease among an Iranian Adult Population with Ethnic and Genetic Diversity: Results of the PolyIran-Liver Study.伊朗具有种族和基因多样性的成年人群中代谢功能障碍相关脂肪性肝病的患病率及特征:PolyIran-肝脏研究结果
Middle East J Dig Dis. 2024 Apr;16(2):86-95. doi: 10.34172/mejdd.2024.374. Epub 2024 Apr 30.
4
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.非酒精性脂肪性肝病或代谢相关脂肪性肝病患者 2 型糖尿病的全球流行病学:系统评价和荟萃分析。
BMC Med. 2024 Mar 6;22(1):101. doi: 10.1186/s12916-024-03315-0.
5
A qualitative study to inform the development of a subsidized community-supported agriculture program for Chinese Americans in Brooklyn, New York, U.S.一项定性研究,旨在为美国纽约布鲁克林的华裔美国人制定一项补贴型社区支持农业计划提供信息。
Prev Med Rep. 2023 Oct 14;36:102480. doi: 10.1016/j.pmedr.2023.102480. eCollection 2023 Dec.
6
Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update.新冠病毒病合并非酒精性脂肪性肝病患者的肝损伤:最新进展
Arch Med Sci Atheroscler Dis. 2023 Feb 23;8:e1-e10. doi: 10.5114/amsad/160950. eCollection 2023.
7
NAFLD: Mechanisms, Treatments, and Biomarkers.非酒精性脂肪性肝病:发病机制、治疗方法及生物标志物
Biomolecules. 2022 Jun 13;12(6):824. doi: 10.3390/biom12060824.
8
Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017-2018.非酒精性脂肪性肝病在 2017-2018 年全国健康和营养调查中的亚裔美国人中的流行率和严重程度。
Hepatol Commun. 2022 Sep;6(9):2253-2261. doi: 10.1002/hep4.1981. Epub 2022 May 9.
9
Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity.非酒精性脂肪性肝病的异质性:对临床实践和研究活动的影响。
World J Hepatol. 2021 Nov 27;13(11):1584-1610. doi: 10.4254/wjh.v13.i11.1584.
10
Associations of Dietary Lipid-Soluble Micronutrients with Hepatic Steatosis among Adults in the United States.美国成年人膳食脂溶性微量营养素与肝脂肪变性的关联。
Biomedicines. 2021 Aug 26;9(9):1093. doi: 10.3390/biomedicines9091093.

本文引用的文献

1
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.慢性斑块状银屑病患者非酒精性脂肪性肝病的患病率、特征及严重程度
J Hepatol. 2009 Oct;51(4):778-86. doi: 10.1016/j.jhep.2009.06.008. Epub 2009 Jun 26.
2
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.2型糖尿病患者中非酒精性脂肪性肝病的患病率。
J Assoc Physicians India. 2009 Mar;57:205-10.
3
Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者纤维化的独立预测因子。
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1224-9, 1229.e1-2. doi: 10.1016/j.cgh.2009.06.007. Epub 2009 Jun 25.
4
Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者纤维化无创标志物的比较
Clin Gastroenterol Hepatol. 2009 Oct;7(10):1104-12. doi: 10.1016/j.cgh.2009.05.033. Epub 2009 Jun 10.
5
Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis.一组墨西哥非酒精性脂肪性肝炎患者体内的脂肪因子
Ann Hepatol. 2009 Apr-Jun;8(2):123-8.
6
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.国际专家委员会关于糖化血红蛋白检测在糖尿病诊断中作用的报告。
Diabetes Care. 2009 Jul;32(7):1327-34. doi: 10.2337/dc09-9033. Epub 2009 Jun 5.
7
Long-term follow-up of patients with nonalcoholic fatty liver.非酒精性脂肪肝患者的长期随访
Clin Gastroenterol Hepatol. 2009 Feb;7(2):234-8. doi: 10.1016/j.cgh.2008.11.005. Epub 2008 Nov 7.
8
Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option?血管紧张素受体阻滞剂治疗 NASH/NAFLD:它们能否成为首选?
Adv Ther. 2008 Nov;25(11):1141-74. doi: 10.1007/s12325-008-0110-2.
9
A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).一种用于肥胖相关非酒精性脂肪性肝炎(NASH)的新型诊断生物标志物组合。
Obes Surg. 2008 Nov;18(11):1430-7. doi: 10.1007/s11695-008-9506-y. Epub 2008 May 24.
10
Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides.肥胖门诊中的种族与非酒精性脂肪性肝病:甘油三酯的影响
Dig Dis Sci. 2008 May;53(5):1358-63. doi: 10.1007/s10620-008-0234-x. Epub 2008 Mar 18.